Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA6 | P23280 | 4/20 | 0.38 |
| ▸ | CA7 | P43166 | 4/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA4 | P22748 | 3/20 | 0.38 |
| ▸ | CA5A | P35218 | 3/20 | 0.38 |
| ▸ | CA3 | P07451 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | GGT1 | P19440 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29736046 | 0.92 | CA12 (0.36) | CA12CA6CA7CA9CA14 | |
| SCHEMBL15319486 | 0.88 | — | — | |
| SCHEMBL29060972 | 0.87 | CA12 (0.39) | CA12CA6CA7CA9CA14 | |
| SCHEMBL29109505 | 0.85 | GGT1 (0.33) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28988287 | 0.85 | SIGMAR1 (0.33) | CA12CA6CA7CA9CA14 | |
| Bromide SCHEMBL8397267 | 0.83 | CA12 (0.31) | CA12CA6CA7CA9CA14 | |
| Alcohol SCHEMBL9008030 | 0.79 | LMNA (0.37) | LMNATDP1GGT1KDM4E | |
| SCHEMBL13764626 | 0.78 | CA12 (0.38) | CA12CA6CA7CA9CA14 | |
| SCHEMBL19934807 | 0.78 | — | — | |
| SCHEMBL10974606 | 0.78 | DNM1 (0.41) | MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067858-A1 | ALIPHATIC EPOXY RESIN CROSSLINKED POLYMERS FOR PRIMARY CEMENTING IN A BOREHOLE | SAUDI ARABIAN OIL COMPANY (SA) | 2024-02-29 | — | — | US | claimed |
| EP-4374157-A2 | FRET-BASED ASSAYS | The General Hospital Corporation (US) | 2024-05-29 | — | — | EP | disclosed |
| US-20240067858-A1 | ALIPHATIC EPOXY RESIN CROSSLINKED POLYMERS FOR PRIMARY CEMENTING IN A BOREHOLE | SAUDI ARABIAN OIL COMPANY (SA) | 2024-02-29 | — | — | US | disclosed |
| WO-2023004438-A2 | FRET-BASED ASSAYS | THE GENERAL HOSPITAL CORPORATION (US) | 2023-01-26 | — | — | WO | disclosed |
| US-11217435-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2022-01-04 | — | — | US | disclosed |
| US-20200090917-A1 | TUNED SYNTHETIC DENDRIMER CALIBRANTS FOR MASS SPECTROMETRY | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2020-03-19 | — | — | US | disclosed |
| US-10347476-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2019-07-09 | — | — | US | disclosed |
| US-9713623-B2 | Triazine cationic polymers and methods of use thereof | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (US) | 2017-07-25 | — | — | US | disclosed |
| US-20150273073-A1 | TRIAZINE CATIONIC POLYMERS AND METHODS OF USE THEREOF | THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A/ CAROLINAS HEALTHCARE SYSTEM | 2015-10-01 | — | — | US | disclosed |
| US-20150132854-A1 | Tuned Synthetic Dendrimer Calibrants for Mass Spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11217435-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | SRMS, SRM, DNMT1 | CA12 703/4885CA6 2567/4885CA7 2502/4885 |
| US-10347476-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | SRMS, SRM, DNMT1 | CA12 912/4885CA6 2829/4885CA7 2591/4885 |
| US-20150273073-A1 | TRIAZINE CATIONIC POLYMERS AND METHODS OF USE THEREOF | SMN1; SMN2, TNNT2, MTPN | CA12 2516/4885CA6 3072/4885CA7 2492/4885 |
| US-20200090917-A1 | TUNED SYNTHETIC DENDRIMER CALIBRANTS FOR MASS SPECTROMETRY | SRMS, SRM, DNMT1 | CA12 703/4885CA6 2567/4885CA7 2502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.